Skip to main content

Mucinex D FDA Approval History

FDA Approved: Yes (First approved June 22, 2004)
Brand name: Mucinex D
Generic name: guaifenesin and pseudoephedrine
Dosage form: Extended-Release Tablets
Company: Adams Respiratory Therapeutics
Treatment for: Cough and Nasal Congestion

Mucinex D (guaifenesin and pseudoephedrine) is an expectorant and decongestant combination used for the relief of coughs and congestion associated with colds and allergies.

Development timeline for Mucinex D

Jun 22, 2004Approval Mucinex D Adams Respiratory Therapeutics - Treatment for Cough and Congestion

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.